Search

Meera Natarajan

Examiner (ID: 11780, Phone: (571)270-3058 , Office: P/1643 )

Most Active Art Unit
1643
Art Unit(s)
1643
Total Applications
1062
Issued Applications
625
Pending Applications
87
Abandoned Applications
376

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6925398 [patent_doc_number] => 20050238653 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-27 [patent_title] => 'Pharmaceutical compositions containing extracted MHC molecules, for stimulation of the immune system' [patent_app_type] => utility [patent_app_number] => 11/107782 [patent_app_country] => US [patent_app_date] => 2005-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 2660 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0238/20050238653.pdf [firstpage_image] =>[orig_patent_app_number] => 11107782 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/107782
Pharmaceutical compositions containing extracted MHC molecules, for stimulation of the immune system Apr 17, 2005 Abandoned
Array ( [id] => 7111197 [patent_doc_number] => 20050208652 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-22 [patent_title] => 'Isogenic beta-catenin cell lines, and methods of making and using same' [patent_app_type] => utility [patent_app_number] => 11/104063 [patent_app_country] => US [patent_app_date] => 2005-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13533 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20050208652.pdf [firstpage_image] =>[orig_patent_app_number] => 11104063 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/104063
Isogenic beta-catenin cell lines, and methods of making and using same Apr 10, 2005 Abandoned
Array ( [id] => 7111170 [patent_doc_number] => 20050208625 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-22 [patent_title] => 'Monoclonal antibodies with reduced immunogenicity' [patent_app_type] => utility [patent_app_number] => 11/099331 [patent_app_country] => US [patent_app_date] => 2005-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8612 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20050208625.pdf [firstpage_image] =>[orig_patent_app_number] => 11099331 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/099331
Monoclonal antibodies with reduced immunogenicity Apr 4, 2005 Abandoned
Array ( [id] => 5720367 [patent_doc_number] => 20060073141 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-06 [patent_title] => 'Compositions and methods for treating inflammatory disorders' [patent_app_type] => utility [patent_app_number] => 11/098758 [patent_app_country] => US [patent_app_date] => 2005-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 93372 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0073/20060073141.pdf [firstpage_image] =>[orig_patent_app_number] => 11098758 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/098758
Compositions and methods for treating inflammatory disorders Apr 3, 2005 Abandoned
Array ( [id] => 246752 [patent_doc_number] => 07585503 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-08 [patent_title] => 'Method for detecting multi-drug resistance' [patent_app_type] => utility [patent_app_number] => 11/094704 [patent_app_country] => US [patent_app_date] => 2005-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 26 [patent_no_of_words] => 7639 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 171 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/585/07585503.pdf [firstpage_image] =>[orig_patent_app_number] => 11094704 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/094704
Method for detecting multi-drug resistance Mar 30, 2005 Issued
Array ( [id] => 278117 [patent_doc_number] => 07557193 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-07-07 [patent_title] => 'Glycopeptides derived from pancreatic structures, antibodies and applications thereof in diagnostics and therapeutics' [patent_app_type] => utility [patent_app_number] => 10/593859 [patent_app_country] => US [patent_app_date] => 2005-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 17436 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/557/07557193.pdf [firstpage_image] =>[orig_patent_app_number] => 10593859 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/593859
Glycopeptides derived from pancreatic structures, antibodies and applications thereof in diagnostics and therapeutics Mar 29, 2005 Issued
Array ( [id] => 4572135 [patent_doc_number] => 07858753 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-12-28 [patent_title] => 'Immunoglobulins' [patent_app_type] => utility [patent_app_number] => 10/594293 [patent_app_country] => US [patent_app_date] => 2005-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 32994 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/858/07858753.pdf [firstpage_image] =>[orig_patent_app_number] => 10594293 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/594293
Immunoglobulins Mar 28, 2005 Issued
Array ( [id] => 7168428 [patent_doc_number] => 20050202028 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-15 [patent_title] => 'Binding domain-immunoglobulin fusion proteins' [patent_app_type] => utility [patent_app_number] => 11/088693 [patent_app_country] => US [patent_app_date] => 2005-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 26589 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20050202028.pdf [firstpage_image] =>[orig_patent_app_number] => 11088693 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/088693
Binding domain-immunoglobulin fusion proteins Mar 22, 2005 Issued
Array ( [id] => 7069514 [patent_doc_number] => 20050244899 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-03 [patent_title] => 'Laminin Receptor 1 Precursor Protein (37LRP) epitope delineated by an Hepatocellular carcinoma specific antibody' [patent_app_type] => utility [patent_app_number] => 11/079969 [patent_app_country] => US [patent_app_date] => 2005-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 15820 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20050244899.pdf [firstpage_image] =>[orig_patent_app_number] => 11079969 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/079969
Laminin Receptor 1 Precursor Protein (37LRP) epitope delineated by an Hepatocellular carcinoma specific antibody Mar 13, 2005 Issued
Array ( [id] => 7136746 [patent_doc_number] => 20050181479 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-18 [patent_title] => 'Periplasmic expression of antibodies using a single signal sequence' [patent_app_type] => utility [patent_app_number] => 11/071304 [patent_app_country] => US [patent_app_date] => 2005-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 16907 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20050181479.pdf [firstpage_image] =>[orig_patent_app_number] => 11071304 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/071304
Periplasmic expression of antibodies using a single signal sequence Mar 3, 2005 Abandoned
Array ( [id] => 5682960 [patent_doc_number] => 20060199230 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-07 [patent_title] => 'Use of prostate specific antigen to predict drug response' [patent_app_type] => utility [patent_app_number] => 11/072854 [patent_app_country] => US [patent_app_date] => 2005-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10933 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0199/20060199230.pdf [firstpage_image] =>[orig_patent_app_number] => 11072854 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/072854
Use of prostate specific antigen to predict drug response Mar 2, 2005 Abandoned
Array ( [id] => 5224688 [patent_doc_number] => 20070253954 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-01 [patent_title] => 'Epha4 As Therapeutic Target Of Prc And Pdaca' [patent_app_type] => utility [patent_app_number] => 10/590801 [patent_app_country] => US [patent_app_date] => 2005-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 22001 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20070253954.pdf [firstpage_image] =>[orig_patent_app_number] => 10590801 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/590801
Epha4 As Therapeutic Target Of Prc And Pdaca Feb 17, 2005 Abandoned
Array ( [id] => 5159856 [patent_doc_number] => 20070172900 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-26 [patent_title] => 'Diagnostic marker for cancer' [patent_app_type] => utility [patent_app_number] => 10/589487 [patent_app_country] => US [patent_app_date] => 2005-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13203 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20070172900.pdf [firstpage_image] =>[orig_patent_app_number] => 10589487 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/589487
Diagnostic marker for cancer Feb 15, 2005 Abandoned
Array ( [id] => 4909642 [patent_doc_number] => 20080020408 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-24 [patent_title] => 'Anti-Ube4a/Ufd2b Polyclonal Antibody and Its Use Thereof as Diagnostic and Prognostic Marker of 11Q23 Region Alterations' [patent_app_type] => utility [patent_app_number] => 10/589299 [patent_app_country] => US [patent_app_date] => 2005-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3497 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20080020408.pdf [firstpage_image] =>[orig_patent_app_number] => 10589299 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/589299
Anti-Ube4a/Ufd2b Polyclonal Antibody and Its Use Thereof as Diagnostic and Prognostic Marker of 11Q23 Region Alterations Feb 7, 2005 Abandoned
Array ( [id] => 7050299 [patent_doc_number] => 20050186186 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-25 [patent_title] => 'Compositions for eliciting immune response and methods for using same' [patent_app_type] => utility [patent_app_number] => 11/045357 [patent_app_country] => US [patent_app_date] => 2005-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5419 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20050186186.pdf [firstpage_image] =>[orig_patent_app_number] => 11045357 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/045357
Compositions for eliciting immune response and methods for using same Jan 30, 2005 Abandoned
Array ( [id] => 5738467 [patent_doc_number] => 20060008858 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-12 [patent_title] => 'Osteoblast factor(s) that regulates human prostate cancer migration to and invasion of bone' [patent_app_type] => utility [patent_app_number] => 11/046666 [patent_app_country] => US [patent_app_date] => 2005-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7336 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20060008858.pdf [firstpage_image] =>[orig_patent_app_number] => 11046666 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/046666
Osteoblast factor(s) that regulates human prostate cancer migration to and invasion of bone Jan 27, 2005 Abandoned
Array ( [id] => 5903175 [patent_doc_number] => 20060046257 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-02 [patent_title] => 'Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancer' [patent_app_type] => utility [patent_app_number] => 11/051720 [patent_app_country] => US [patent_app_date] => 2005-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 77 [patent_figures_cnt] => 77 [patent_no_of_words] => 249848 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20060046257.pdf [firstpage_image] =>[orig_patent_app_number] => 11051720 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/051720
Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancer Jan 26, 2005 Issued
Array ( [id] => 4988113 [patent_doc_number] => 20070154452 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-05 [patent_title] => 'Therapeutic agent for pancreas cancer' [patent_app_type] => utility [patent_app_number] => 10/597206 [patent_app_country] => US [patent_app_date] => 2005-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4095 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0154/20070154452.pdf [firstpage_image] =>[orig_patent_app_number] => 10597206 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/597206
Therapeutic agent for pancreas cancer Jan 25, 2005 Abandoned
Array ( [id] => 602594 [patent_doc_number] => 07432357 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-07 [patent_title] => 'Anti-cancer antibodies with reduced complement fixation' [patent_app_type] => utility [patent_app_number] => 11/040071 [patent_app_country] => US [patent_app_date] => 2005-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 12 [patent_no_of_words] => 5492 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/432/07432357.pdf [firstpage_image] =>[orig_patent_app_number] => 11040071 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/040071
Anti-cancer antibodies with reduced complement fixation Jan 20, 2005 Issued
Array ( [id] => 5435579 [patent_doc_number] => 20090170166 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'ANTIBODY INHIBITING URACIL-DNA-GLYCOSYLASE AND USES THEREOF FOR DECONTAMINATING NUCLEIC ACID AMPLIFICATION REACTIONS' [patent_app_type] => utility [patent_app_number] => 10/596965 [patent_app_country] => US [patent_app_date] => 2004-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4603 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20090170166.pdf [firstpage_image] =>[orig_patent_app_number] => 10596965 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/596965
ANTIBODY INHIBITING URACIL-DNA-GLYCOSYLASE AND USES THEREOF FOR DECONTAMINATING NUCLEIC ACID AMPLIFICATION REACTIONS Dec 21, 2004 Abandoned
Menu